Prosecution Insights
Last updated: August 15, 2026

Intra-cellular Therapies Inc.

9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
6
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (22%)
5
Medium (56%)
2
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (22%)
Double-patenting only2 (22%)
Double-patenting + other3 (33%)
Multi-statute (no §101)2 (22%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
78% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
22% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ABDALHAMEED, MANAHIL MIRGHANI ALI 1 50.4% +40.1%
SHIAO, REI TSANG 1 79.8% -33.7%
O DELL, DAVID K 1 57.7% +36.0%
STEVENS, MARK V 1 65.5% +41.9%
RODRIGUEZ, RAYNA B 1 33.1% +20.0%
RODRIGUEZ-GARCIA, VALERIE 1 68.8% +31.9%
CHONG, YONG SOO 1 43.7% +41.7%
FETTEROLF, BRANDON J 1 51.4% +17.1%
SHOWALTER, ALEXANDER KEITH 1 53.6% +32.5%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18596349 NOVEL METHODS STEVENS, MARK V 14d
18567743 NOVEL SALTS AND CRYSTALS RODRIGUEZ, RAYNA B

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18007018 NOVEL USES SHOWALTER, ALEXANDER KEITH 60d overdue
18042103 ORGANIC COMPOUNDS FETTEROLF, BRANDON J 3d overdue
18596349 NOVEL METHODS STEVENS, MARK V 14d
18847121 ORGANIC COMPOUNDS ABDALHAMEED, MANAHIL MIRGHANI ALI
18741740 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS O DELL, DAVID K
18567743 NOVEL SALTS AND CRYSTALS RODRIGUEZ, RAYNA B
18481168 NOVEL METHODS RODRIGUEZ-GARCIA, VALERIE
18320173 NOVEL METHODS CHONG, YONG SOO

Top Art Units

Art UnitApps
1621 1
1613 1
1628 1
1600 1
1623 1
1626 1
1629 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18847121 ORGANIC COMPOUNDS ABDALHAMEED, MANAHIL MIRGHANI ALI §103§112DP Non-Final OA Pending Sep 13, 2024
18777765 NOVEL METHODS SHIAO, REI TSANG DP Non-Final OA Pending Jul 19, 2024
18741740 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS O DELL, DAVID K 1621 §102§103DP Non-Final OA Pending Jun 12, 2024
18596349 NOVEL METHODS STEVENS, MARK V 1613 §103§112Other Non-Final OA 14d Pending Mar 05, 2024
18567743 NOVEL SALTS AND CRYSTALS RODRIGUEZ, RAYNA B 1628 §102§103§112 Non-Final OA Pending Dec 06, 2023
18481168 NOVEL METHODS RODRIGUEZ-GARCIA, VALERIE 1600 §103DP Final Rejection Pending Oct 04, 2023
18320173 NOVEL METHODS CHONG, YONG SOO 1623 DP Final Rejection Pending May 18, 2023
18042103 ORGANIC COMPOUNDS FETTEROLF, BRANDON J 1626 §103 Non-Final OA 3d overdue Pending Feb 17, 2023
18007018 NOVEL USES SHOWALTER, ALEXANDER KEITH 1629 §103 Non-Final OA 60d overdue Pending Jan 26, 2023

Managing Intra-cellular Therapies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month